Amgen Inc

AMGN: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
#h>LOCK|d!HLOCK|tx@zCH@>

Amgen Earnings: Cardiovascular Focus More Apparent in Company's Growth Prospects

Amgen reported 10% revenue and non-GAAP earnings per share growth for 2025. Guidance for 2026 implies 1%-4% top-line growth and 2% non-GAAP EPS growth at the $22.30 midpoint. The shares were relatively flat after hours on Feb. 3.

Sponsor Center